Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 6, 2006, Pages

  Kanetsuna, Yukiko ^a   Hirano, Keita ^a   Nagata, Michio ^b   Gannon, Maureen A ^a   Takahashi, Keiko ^a   Harris, Raymond C ^a   Breyer, Matthew D ^a   Takahashi, Takamune ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Animal model; Diabetic renal disease; Hepatocyte nuclear factor 6; Transgenic mice

Indexed keywords

GELATINASE A; HEPATOCYTE NUCLEAR FACTOR 6; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE FUNCTION; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOINSULINEMIA; IMMUNOHISTOCHEMISTRY; MALE; MESANGIUM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET DISEASE; PRIORITY JOURNAL;

EID: 33845354205     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00379.2005     Document Type: Article

References (35)

1. Allen TJ, Cooper ME, and Lan HY. Use of genetic mouse models in the study of diabetic nephropathy. Curr Diab Rep 4: 435-440, 2004.
2. Anonymous. USRDS 2004 Annual Data Report. Am J Kidney Dis 45: 8-280, 2005.
3. Bloomgarden ZT. Diabetic nephropathy. Diabetes Care 28: 745-751, 2005.
4. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, and Sharma K. Diabetic nephropathy: of mice and men. Adv Chronic Kidney Dis 12: 128-145, 2005.
5. Breyer MD, Bottinger E, Brosius FC, III, Coffman TM, Harris RC, Heilig CW, and Sharma K. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005.
6. Diani AR, Sawada GA, Zhang NY, Wyse BM, Connell CL, Vidmar TJ, and Connell MA. The KKAy mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 24: 297-303, 1987.
7. Doi T, Hattori M, Agodoa LY, Sato T, Yoshida H, Striker LJ, and Striker GE. Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest 63: 204-212, 1990.
8. Dunn SR, Qi Z, Bottinger EP, Breyer MD, and Sharma K. Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int 65: 1959-1967, 2004.
9. Flyvbjerg A, Mogensen CE, Osterby R, and Orskov H. Renal hypertrophy in experimental diabetes. J Diabetes Complications 5: 62-64, 1991.
10. Fujita H, Haseyama T, Kayo T, Nozaki J, Wada Y, Ito S, and Koizumi A. Increased expression of glutathione S-transferase in renal proximal tubules in the early stages of diabetes: a study of type-2 diabetes in the Akita mouse model. Exp Nephrol 9: 380-386, 2001.
11. Gannon M, Ray MK, Van Zee K, Rausa F, Costa RH, and Wright CV. Persistent expression of HNF6 in islet endocrine cells causes disrupted islet architecture and loss of beta cell function. Development 127:2883-2895, 2000.
12. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, and Coffman TM. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290: F214-F222, 2006.
13. Hagenfeldt-Johansson KA, Herrera PL, Wang H, Gjinovci A, Ishihara H, and Wollheim CB. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology 142: 5311-5320, 2001.
14. Haseyama T, Fujita T, Hirasawa F, Tsukada M, Wakui H, Komatsuda A, Ohtani H, Miura AB, Imai H, and Koizumi A. Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse. Tohoku J Exp Med 198: 233-244, 2002.
15. Inada A, Nagai K, Arai H, Miyazaki J, Nomura K, Kanamori H, Toyokuni S, Yamada Y, Bonner-Weir S, Weir GC, Fukatsu A, and Seino Y. Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am J Pathol 167: 327-336, 2005.
16. Leiter EH. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Proc Natl Acad Sci USA 79: 630-634, 1982.
17. Louet JF, LeMay C, and Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6: 180-185, 2004.
18. Marshall SM. Recent advances in diabetic nephropathy. Clin Med 4: 277-282, 2004.
19. Nagata M and Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42: 148-160, 1992.
20. Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, and Carlsson C. Regulation of beta-cell mass by hormones and growth factors. Diabetes 50, Suppl 1: S25-S29, 2001.
21. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, and Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51: 2734-2741, 2002.
22. O'Bryan GT and Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 17: 93-100, 1997.
23. Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, Nagata K, Kita T, Okamoto H, Yamamoto H, and Doi T. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. J Biol Chem 279: 19816-19823, 2004.
24. Pagtalunan ME, Rasch R, Rennke HG, and Meyer TW. Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F82-F88, 1995.
25. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, and Breyer MD. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 286: F590-F596, 2004.
26. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, and Sjoquist M. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20: 532-538, 2005.
27. Sharma K, McCue P, and Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003.
28. Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, and Nakao K. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy. FASEB J 19: 127-129, 2005.
29. Thomson SC, Vallon V, and Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 286: F8-F15, 2004.
30. Ward DT, Yau SK, Mee AP, Mawer EB, Miller CA, Garland HO, and Riccardi D. Functional, molecular, and biochemical characterization of streptozotocin- induced diabetes. J Am Soc Nephrol 12: 779-790, 2001.
31. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest 34: 785-796, 2004.
32. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ, and Lam KS. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280: 18073-18080, 2005.
33. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, and Yamamoto H. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 108: 261-268, 2001.
34. Yoshioka M, Kayo T, Ikeda T, and Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46: 887-894, 1997.
35. Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, and Epstein PN. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53: 3248-3257, 2004.